Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells
Crossref DOI link: https://doi.org/10.1007/s00262-016-1816-7
Published Online: 2016-03-10
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Foy, Susan P.
Mandl, Stefanie J.
dela Cruz, Tracy
Cote, Joseph J.
Gordon, Evan J.
Trent, Erica
Delcayre, Alain
Breitmeyer, James
Franzusoff, Alex
Rountree, Ryan B.
License valid from 2016-03-10